N/A N=14 Randomized Treatment

Electrical Stimulation in Diabetic Peripheral Neuropathy

NMES · Control

Bottom Line

View on ClinicalTrials.gov: NCT02082145 ↗

Enrolled (actual)

Serious AEs

0.0%

Results posted

Oct 2019

Primary outcome: Primary: Nerve Conduction Speed (Common Peroneal Nerve) — 33.93; 44.1; 41.63; 44.13 m/sec

Study Design & Population

Study type: Interventional
Phase: N/A
Interventions: NMES (Device)
Age: Adult, Older Adult · 18+ yrs
Sex: All
Sponsor: Imperial College London
Primary completion: Dec 2015

Outcome Measures

Outcome	Result	p-value
PRIMARY Nerve Conduction Speed (Common Peroneal Nerve)	33.93; 44.1; 41.63; 44.13	—
SECONDARY PAID - Quality of Life Questionnaires	26.2; 27.4; 40.29; 5	—

Summary

To assess the effect of the device on the progression of diabetic peripheral neuropathy

Eligibility Criteria

Inclusion criteria

18+ years old
Diabetes as defined by WHO diagnostic criteria on best medical therapy
Diabetic peripheral polyneuropathy present, confirmed by nerve conduction testing

Exclusion criteria

Pregnancy
Pacemaker
Metal implants in the legs (below knee)

View full record on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov (NCT02082145). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.